Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Benitec Biopharma Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −4 vs. Q4 2022
- Shares held
- 11.6M
- −674.5K (−5.5%) vs. Q4 2022
- Total value
- $2.44M
- +$351.8K (+16.8%) vs. Q4 2022
- New holders
- 1
- 2 more added
- Sold out
- 5
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BNTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $443.3M |
| Q1 2026 | 88 | $346.0M |
| Q4 2025 | 72 | $426.6M |
| Q3 2025 | 56 | $324.7M |
| Q2 2025 | 57 | $265.3M |
| Q1 2025 | 37 | $290.1M |
| Q4 2024 | 30 | $240.2M |
| Q3 2024 | 25 | $126.8M |
| Q2 2024 | 19 | $44.3M |
| Q1 2024 | 13 | $6.58M |
| Q4 2023 | 13 | $3.88M |
| Q3 2023 | 12 | $3.84M |
| Q2 2023 | 17 | $2.45M |
| Q1 2023 | 21 | $2.44M |
| Q4 2022 | 25 | $2.09M |
| Q3 2022 | 25 | $5.92M |
| Q2 2022 | 22 | $1.55M |
| Q1 2022 | 21 | $2.60M |
| Q4 2021 | 17 | $4.16M |
| Q3 2021 | 19 | $5.43M |
| Q2 2021 | 18 | $6.46M |
| Q1 2021 | 15 | $1.84M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Benitec Biopharma Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cutler Group LP | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 193 | $41 | 0.00% | +2+1.0% | Added |
| UBS Group AG | 347 | $73 | 0.00% | −927−72.8% | Reduced |
| Rosenberg Matthew Hamilton | 381 | $80 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,500 | $315 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 7,561 | $2.00K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,813 | $2.48K | 0.00% | 00.0% | Unchanged |
| Cetera Advisor Networks LLC | 12,351 | $2.59K | 0.00% | −4,282−25.7% | Reduced |
| WealthTrust Axiom LLC | 12,950 | $2.72K | 0.00% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 13,157 | $2.76K | 0.00% | +13,157 | New |
| State Street Corp | 21,438 | $4.50K | 0.00% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 25,050 | $5.26K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 26,747 | $5.61K | 0.00% | −2,206−7.6% | Reduced |
| Morgan Stanley | 45,500 | $9.55K | 0.00% | −323,423−87.7% | Reduced |
| Geode Capital Management, LLC | 48,223 | $10.1K | 0.00% | −1,246−2.5% | Reduced |
| Vanguard Group Inc | 74,773 | $15.7K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 121,514 | $26.0K | 0.00% | +40,647+50.3% | Added |
| Walleye Capital LLC | 215,989 | $45.3K | 0.00% | −128,026−37.2% | Reduced |
| Renaissance Technologies LLC | 224,879 | $47.0K | 0.00% | −150,652−40.1% | Reduced |
| Suvretta Capital Management, LLC | 769,000 | $161.4K | 0.01% | 00.0% | Unchanged |
| Franklin Resources Inc | 10,000,000 | $2.10M | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −55,078−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −27,475−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −23,200−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,481−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −300−100.0% | Sold out |